Allergy Therapeutics Plc (AGY) Ord GBP0.01
0.075p
(0.90%)
- Add to watchlist
- Create an alert
- This stock can be held in a
0.075p
(0.90%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
0.075p
(0.90%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
Share news, reports & tips
-
Allergy Therapeutics starts dosing peanut allergy vaccine candidate
27 March 2023 15:16
(Sharecast News) - Allergy Therapeutics, a UK-based biotechnology company specialising in allergy vaccines, announced the start of the first application of its 'VLP Peanut' vaccine candidate in...
-
Allergy Therapeutics confident in funding as results remain late
20 January 2023 12:33
(Sharecast News) - Commercial biotechnology company Allergy Therapeutics said in an update on Friday that it expects first-half revenue of £39.9m, making for a decrease of 18% year-on-year.
Company announcements Announcements
-
Company to Evaluate Dual Listing on HKEX
6 November 2025 07:22
Allergy Therapeutics
-
G308 Phase III Year 2 Patient Screening Starts
30 October 2025 07:00
Allergy Therapeutics
-
Warrant Exercise and Paydown of Debt
29 October 2025 07:00
Allergy Therapeutics
-
Further progress in Phase I/IIa PROTECT trial
16 October 2025 07:00
Allergy Therapeutics
-
Grass MATA MPL Publications in Allergy Journal
31 July 2025 07:00
Allergy Therapeutics
-
Trading update for the year ended 30 June 2025
21 July 2025 07:00
Allergy Therapeutics
-
PDMR Dealings
11 July 2025 07:00
Allergy Therapeutics
-
Allergy Therapeutics presents findings at EAACI
13 June 2025 07:00
Allergy Therapeutics
-
EAACI Early Career Research Award
10 June 2025 07:04
Allergy Therapeutics
-
Interim Results for six months ended 31 Dec 2024
31 March 2025 07:00
Allergy Therapeutics
-
Advancement to final phase of PROTECT trial
27 March 2025 07:00
Allergy Therapeutics
-
New Executive Long Term Incentive Awards
3 March 2025 07:00
Allergy Therapeutics
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2025. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.